No earnings within 2 weeks of this transaction.
| Insider | Amado Rafael |
|---|---|
| Title | President, Head of Global Oncology Research and Development |
| Transaction Date | Dec 30, 2025 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Restricted Share Units |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Jan 2, 2026 |
| Document Date | Dec 30, 2025 |
| Shares Purchased | 21,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 42,000 |
| Derivative | Derivative |
| Accession Number | 0000905148-26-000003 |
| Document | View SEC Filing |